Developing new cancer treatments
DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM
This study is all about finding new medicines to help treat cancer by testing a huge number of different compounds, and it aims to create better treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10716676 on NIH RePORTER |
What this research studies
This research focuses on discovering and developing new agents that can be approved as cancer therapeutics. It involves a complex process that includes high throughput screening of over 200,000 compounds to identify potential drug candidates. The project requires flexibility and adaptability as it navigates various technical challenges and biological hurdles throughout the drug discovery process. Patients may benefit from innovative treatments that emerge from this extensive research effort.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with various types of cancer who are seeking new treatment options.
Not a fit: Patients with non-malignant conditions or those who are not currently diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, effective cancer therapies that improve patient outcomes.
How similar studies have performed: Previous research in cancer drug discovery has shown success with similar high throughput screening approaches, indicating a promising potential for this project.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Difilippantonio, Michael — Leidos Biomedical Research, INC.
- Study coordinator: Difilippantonio, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.